View Article

Abstract

Bioanalytical method development is essential for the accurate quantification of drugs and their metabolites in biological matrices such as plasma, serum, or urine Techniques like liquid-liquid extraction (LLE), solid phase extraction (SPE), and protein precipitation are commonly used to isolate analytes from complex biological samples. Among various analytical tools, HPLC is widely preferred due to its speed, specificity, accuracy, and precision. HPLC is especially suitable for analysing low dose drugs and multicomponent formulations, making it a critical component in pharmaceutical research and development. Method development and validation are vital at all stages of drug discovery and manufacturing to ensure that analytical procedures are fit for their intended purpose. Regulatory bodies require validated methods for various stages of drug development, including Investigational New Drug (IND) applications, New Drug Applications (NDA), and Abbreviated New Drug Applications (ANDAs). Validated HPLC methods support pharmacokinetic and toxicokinetic studies, which are essential for assessing drug safety and efficacy. This article focusing on parameters such as selectivity, sensitivity, linearity, precision, accuracy, and stability. The development of robust HPLC methods contributes significantly to the success of new drug applications and ongoing pharmaceutical research.

Keywords

High Performance Liquid Chromatography, Bioanalytical, Validation, Method development, etc

Introduction

  1. High Performance Liquid Chromatography

HPLC is powerful and widely used approach for isolating, determining, and measuring particular components in a liquid mixture. [1] When assessing new formulations, monitoring reaction changes throughout synthesis processes or scale up, verifying the peak purity of novel chemical entitis, and performing quality control and assurance on the finished drug products, HPLC is the preferred technique. [2] It is a more advanced form of a liquid chromatography that uses high pressure to move a solvent (the mobile phase) through a stationary phase packed column. HPLC has isolated each individual chemical component from the sample mixture based on its unique affinities for the mobile phase or adsorbent substance in the column, causing various constituents to separate in the column, causing various constituents to separate as they travel at different velocities. [3]

    1. Principle

HPLC works on the basis of separating components interactions with a stationary phase as they get carried by a mobile phase. Small particle size of stationary phase which gives high surface area to make separation more specific and precise. The use of micro syringes allows samples to be injected into pumps that provide high pressure flow of the mobile phase. [4] When small volume of analyte is injected into column the components will move with different affinity in column and separate out with different retention time and on recorder will give distinct and resolved peaks which is used in analysis of analyte. [5]

    1. Classification of HPLC can be done as [6]

HPLC is often divided into two subclasses according on the mode of operation:

  1. NP-HPLC

 The term “Normal Phase High Performance Liquid Chromatography” (NP-HPLC) refers to methods where the mobile phase is less polar than the stationary phase. In NP- HPLC SiO2, NH2, -CN, NO2, ALO3 and diol are used as stationary phase and cyclohexane [7-8]

  1. RP-HPLC

In RP-HPLC mobile phase used is polar or slightly polar, but the SP is non poIar. Separation is primarily based on hydrophobic interactions. [9] Non-polar analytes in the polar mobile phase are attracted to and interact effectively with non-polar SP, leading to longer retention. Polar analytes have weak interactions with the SP and elute quickly as they are more soluble in the polar MP. [10]

    1. Instrumentation

The common parts of HPLC instrumentation are

  1. Solvent reservoir
  2. Pumps
  3. Sample injector
  4. Column
  5. Detector

Figure 1: Schematic diagram of HPLC

  1. Solvent reservoir

A reservoir made of glass holds the contents of the mobile phase. The polar and non- polar liquid components that make up the mobile phase, or solvent, in HPLC are often mixed together, and the amounts of these components vary based on the sample’s makeup. Usually polar and non-polar solvents are stored separately in different container and used in proper ratio in isocratic and gradient elution. [11-12]

  1. Pumps

Pumps are designed to prevent pulsation during the change in composition of mobile phase. HPLC pump continuously pump the mobile phase towards the column with constant pressure and constant flow rate of pump may up to 200 bar depending upon flow rate. Depending on needs of the analysis, the operational pressure limits can vary greatly, ranging from 2000 to 5000 psi in normal analytical operation. [13-14] Three commonly used pump types are

  • Constant pressure pump: This uses pressure from a gas cylinder to generate a steady, continuous flow rate across the column. The solvent chamber can be quickly refilled due to the valve configuration. To produce high liquid pressures, a low-pressure gas source is required.
  • Syringe type pump: The column receives the steady flow rate through a controlled anchor mechanism. Adjusting the motor’s voltage determines the solvent supply rate. Significant drawbacks include restricted solvent storage and restricted gradient operation.
  • Resiprocating piston pump: These uses the rotating action of a piston in a hydraulic chamber to deliver the solvents. Because one pump is in the delivery cycle and the other is in the filling cycle, reciprocating pump systems provide smooth solvent supply. Both gradient operation and high pressure output at a consistent flow rate are achievable.
  1. Sample Injector

Sample injector used to add the sample to the active mobile phase. Liquid samples with a volume of 0.1-100 mL can be loaded into an HPLC injector with excessive pressure (in the range of to 4,000 psi) and satisfactory reproducibility. When a user has to detect a more number of samples, an auto sampler is an automatic version. Samples are injected into the mobile phase stream at a fixed volume using injectors. To maintain a high degree of accuracy, injection must be inert and repeatable. [15-16] The sample can be introduced into the injection port in three crucial ways.

  • Loop Injection: In this type, fixed volume loop injector is used to introduce a fixed quantity of volume.
  • Valve Injection: This makes an use of an injection valve to introduce an alterable volume.
  • On column Injection: In which, a syringe is used to insert a varied volume through a septum.
  1. Column

Made mostly of clean stainless steel, columns have internal dimensions of 2 to 5 mm in width and 50 to 300 mm in length. Columns are packed with a SP that contains particles between 3 to 10 µm. Microbore columns have internal diameter of less than 2 mm. During the analysis, maintaining a constant temperature for both the column and the MP is adequate. [17] Various column types are- 1) Guard columns and 2) Analytical columns [18]

Guard column: It prolongs the lifespan of analytical column by eliminating impurities and particulate, matter from solvents. It has same composition compared to analytical column, but it has large particle size.

Analytical column: It is referred to as heart of HPLC, as from it mobile phase continuously passes. The length of column can be vary from 10 to 30 cm with diameter of 4 to 10 mm.

  1. Detector

Every molecule that elutes from the chromatographic column can be identified by the HPLC detector. The detectors include electrochemical, ultraviolet spectroscopy, mass spectrometric, fluorescence, and evaporative light scattering detectors are utilized.  Detector supplied an output from the detector to a computer or recorder, which produces the graph, or a liquid chromatogram of the detector output. Both the necessary sensitivity and a particular response are provided by a detector for the components that the column separates. [19]

Table 1: Detector and their applications

 

Detector

Analytes

Solvent requirement

1

UV Visible

Any with chromophores

UV grade non-UV absorbing

2

Fluorescence

Fluorescent

UV grade non-UV absorbing solvents

3

Refractive index (RI)

Compound with a different RI to that of mobile phase

Cannot run mobile phase gradients

4

Conductivity

Charged/ polar compounds

Mobile phase must be conducting

5

Mass spectrometer (MS)

Broad range of compounds

Must use volatile solvent and volatile buffers

1.4 Application of HPLC [20]

1. Pharmaceutical application

HPLC has a high linear dynamic range and reliable quantitative precision and accuray, it can be used to quantify various substances in a single run. A useful method for preparing samples for solid dosage forms in aqueous solutions that have been altered with acetonitrile or methanol. There are several ways to separate chiral substances into their respective enantiomers using HPLC. Precolumn derivatization is one method of creating diastereomers.

2. Manufacturing

There are several uses for HPLC in experimental and therapeutic science. This technique is commonly used in pharmaceutical manufacturing as it is an accurate way to determine and confirm the purity of the product. HPLC is not often the primary method used in the production of bulk pharmaceutical compounds, although its ability to yield very pure and superior products. Unfortunately, HPLC tends to increase specificity, precision and accuracy at the expense of increased cost. 

3. Research [21]

Research may determine the concentration of potential medicinal candidates, such as asthma drugs and antifungal treatments, using similar assays techniques. When attempting to determine the identify of a species, this method necessitates the use of standard solutions, because purity is crucial in research, it is employed as a technique to verify the outcomes of synthesis procedures. It is definitely useful in observing a variety of species in sample collection also.

4. Medical

Drug analysis is one application of HPLC in medicine, but it is more closely related to nutrient analysis. The most common medium for detecting medication concentrations is urine, but usually medical analyses utilizing HPLC use blood serum as the sample. Other techniques, such as immunoassays, for detecting chemicals that are relevant for clinical research has been evaluated against HPLC. In one instance, the sensitivity of HPLC and competitive protein binding assays (CPBA) for vitamin D detection was evaluated.

  1. Foods

High-performance liquid chromatography has improved food analysis in ways that are desired. In general, food matrices are complicated, and extracting analytes is a challenging process. Trace elements often contain both unwanted and useful components, and conventional separation and evaluation techniques are not accurate or precise enough to make matters more problematic.

1.5 System Suitability Parameters

A crucial component of the liquid chromatographic approach is a system suitability test. They are used in analysis to make sure that the chromatographic system has adequate resolution and reproducibility. The test’s foundation is the idea that the apparatus, electronics, investigative process, and tester under analysis form a single, integrated system that should be assessed as such. [22] System performance before or during analysis is confirm by determining the parameters such as resoIution, pIate count, reproducibility and taiIing factor. [23]

  1. Retention time (RT)

 Retention time is the interval of time between the injection site and peak maximum appearance. Additionally, it can refer to the time it takes for half of a component to come out from a column. The measuring units are minutes and seconds.

  1. Theoretical plates (N)

An alternative name for it is column efficiency. Wherever the distribution of the tester between liquid-liquid or solid- solid segment takes place, a column can be seen of as consisting of a large no. of theoretical plates. To determine TP formula is given below:      N=16RTW2

Where RT= Retention time and w= Width at the peak’s base.

Reference

  1. Y. Kazakevich, R. Lobrutto, HPLC for Pharmaceutical Scientists, John Wiley & Sons, New Jersey, 2007.
  2. S. Ahuja, H. Rasmussen, Development for Pharmaceuticals, Vol.8 Separation Science and Technology, Elsevier, New York 2007.
  3. Y. Vander Heyden, A. Nijhuis, J. Smeyers-Verbeke, B.G.M. Vandeginste, D.L. Massart, Guidance for robustness: ruggedness tests in method validation, J. Pharm. Biomed. Anal. 24 (2001) 723–753.
  4. M.S. Charde, A.S. Welankiwar, J. Kumar, Method development by liquid chromatography with validation, International Journal of Pharmaceutical Chemistry, 04 (02) (2014) 57-61.
  5. Kumar V, Bharadwaj R, Gupta G, Kumar S. An Overview on HPLC Method Development,
  6. Sánchez MLF. Chromatographic techniques, European RTN Project, GLADNET, retrieved on 05-09-2013.
  7. Snyder LR, Kirkland JJ, Glach JL. Practical HPLC Method Development, John Wiley and Sons, New York, 1997; 158-192.
  8. HPLC – Chemiguide. May 2, 2007. www.chemguide.co.uk
  9.  Rao G, Goyal A. An Overview on Analytical Method Development and Validation by Using HPLC. The Pharmaceutical and Chemical Journal, 2016; 3(2): 280-289.
  10. McpolinOona.an Introduction to HPLC for Pharmaceutical Analysis. Mourne Training Service. 11-12.
  11. Bachhav P, et al. Review of High-Performance Liquid Chromatography and Its Applications. RRJ Pharm Pharm Sci. 2023; 12:004. DOI: 10.4172/2320-1215.12.3.004
  12. Bergh JJ, Breytenbach JC. Stability-indicating high-performance liquid chromatographic analysis of trimethoprim in pharmaceuticals. J Chromatogr. 1987 Jan 30; 387:528-31. doi: 10.1016/s0021-9673(01)94565-0.
  13. Haginaka J, Yasuda H, Uno T, Nkagawa T. Alkaline degradation and determination by high-performance by high-performance liquid chromatography. Chemical Pharmacy. Bullet. 1984; 32: 2752-2758
  14. Haginaka J, Yasuda H, Uno T, Nkagawa T. Alkaline degradation and determination by high-performance by high-performance liquid chromatography. Chemical Pharmacy. Bullet. 1984; 32: 2752-2758
  15. Fredj G, Paillet M, Aussel F, Brouard A, Barreteau H, Divine C, Micaud M. Determination of sulbactam in biological fl uids by high-performance liquid chromatography. J Chromatogr. 1986 Nov 28;383(1):218-22. doi: 10.1016/s0378-4347(00)83464-7.
  16. Horvath Cs, et al. Fast liquid chromatography, Investigation of operating parameters and the separation of nucleotides on pellicular ion exchangers. Anal Chem. 1967; 39:1422–1428
  17. Polite L. Liquid chromatography: basic overview. In: Miller J, Crowther JB [eds], Analytical chemistry in a GMP environment: a practical guide. John wiley & sons, New York. 2000.
  18. G Vidyasagar. Instrumental methods of drug analysis. 2010;1.
  19. Rodenas V, Garcia MS, Sanchez-Pedreno C, Albero MI. Flow-injection spectrophotometric determination of frusemide or sulphathiazole in pharmaceuticals. Journal of Pharmacy and Biomedical Analyst. 1997; 15: 1687-1693.
  20. Ali AH. High-Performance Liquid Chromatography (HPLC): A review. Ann Adv Chem. 2022; 6: 010-020. DOI: 10.29328/journal.aac.1001026.
  21. Rachit Shukla et al. Ijppr.Human, 2023; Vol. 27 (1): 312-324.
  22. Vidushi Y, Meenakshi B, Bharkatiya M. A review on HPLC method development and validation. Res J Life Sci, Bioinform, Pharm Chem Sci. 2017;2(6):178.
  23. Bose A. HPLC calibration process parameters in terms of system suitability test. Austin Chromatogr. 2014;1(2):1-4.
  24. Kumar GT, Andrews BS, Abbaraju VK. The Significance of System Suitability in High-Performance Liquid Chromatography (HPLC) Analysis: Ensuring Accurate and Reliable Results.
  25. Kumar, Sanjay D., and DR Harish Kumar. "Importance of RP-HPLC in analytical method development: a review." International journal of pharmaceutical sciences and research 3.12 (2012): 4626.
  26. Snyder, L.R., J.J. Kirkland and J.L. Glajch, 1997. (65:35). Practical HPLC Method Development, 2 Edition, Wiley-Interscience, New York, pp: 41-43.
  27. Kumar SD, Kumar DH. Importance of RP-HPLC in analytical method development: a review. International journal of pharmaceutical sciences and research. 2012 Dec 1;3(12):4626.
  28. Ashri NY, Abdel-Rehim M. Sample treatment based on extraction techniques in biological matrices. Bioanalysis. 2011 Sep 1;3(17):2003-18.
  29. Kamalraj R, Devdass G, Rajalakshmi V and Nithin J. Bioanalytical method development models and validation for drug and its metabolite by using LCMS/MS: A Review Journal of Pharmacy Research, 2012, 5, 377-380.
  30. Kamalraj R, Devdass G, Rajalakshmi V and Nithin J. Bioanalytical method development models and validation for drug and its metabolite by using LCMS/MS: A Review Journal of Pharmacy Research, 2012, 5, 377-380.
  31. Kirthi A, Shanmugam R, Prathyusha MS, Basha DJ
  32. A. V. Eeckhaut, K. Lanckmans, S. Sarre, I. Smolders, Y. Michotte, Validation of bioanalytical LC–MS/MS assays: Evaluation of matrix effects, J. Chromatogr. B. 2009; 877: 2198–2207.
  33. M. Ahnoff, A-C. Nyström, F. Schweikart, A. Ekdahl, Matrix effect explained by unexpected formation of peptide in acidified plasma, Bioanalysis. 2015; 7: 295-306.
  34. Paterson S, Cordero R, Burlinson S. Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 813:323-30.
  35. Tiwari G, Tiwari R. Bioanalytical method validation: An updated review. Pharmaceutical methods. 2010 Oct 1;1(1):25-38.
  36. Wood R. How to Validate Analytical Methods. Trends Analyt Chem 2005; 18:624-132.
  37. Shah RS, Pawar RB, Gayakar PP. An analytical method development of HPLC.International Journal of Institutional Pharmacy and Life Sciences. 2015; 5(5): 506-513.
  38. Chetta N. et.al. Development and validation of a stability indicating high performance liquid chromatographic (HPLC) method for Atenolol and hydrochlorothiazide in bulk drug and tablet formulation. Int J Chem tech res. 2013; 1(3): 654-662.
  39. ICH Q2 (R1) Validation of Analytical Procedures: Text and Methodology. International Conference on Harmonization, IFPMA, Geneva; 2005.
  40. Vij M, Dand N, Kumar L, Ankalgi A, Wadhwa P, Alshehri S, Shakeel F, Ghoneim MM, Alam P, Wani SU. RP-HPLC-based bioanalytical approach for simultaneous quantitation of cinnarizine and domperidone in rat plasma. Separations. 2023 Mar;10(3):159.
  41. Kumar P, Shukla S, Subudhi BB, Ganure AL. Bioanalytical method development and validation for the simultaneous estimation of thiocolchicoside and lornoxicam in human plasma and in pharmaceutical dosage form by RP-HPLC. Intern. J. Pharm. Pharm. Sci. 2012; 4:251-9.
  42. Kharkar P, Talkar S, Patravale VB. A rapid and sensitive bio analytical RP-HPLC method for detection of docetaxel: development and validation. Indian J Pharm Educ. 2017 Oct 1;51(4):729-34.
  43. Kumar A, Dhiman C, Kumar M, Kannappan N, Kumar D, Chourasia MK, Narayan KP. Development of a quality by design-based hybrid RP-HPLC method for Glimepiride: Bioanalytical and industrial applications. Journal of Applied Pharmaceutical Science. 2025 Jan 27.
  44. D’cruz D, Babu A, Joshy E, Aneesh TP. Bioanalytical method development and validation of ticagrelor by RP-HPLC. Int J App Pharm. 2017 May 1;9(3):51-4.
  45. Duse PV, Baheti KG. Bioanalytical method development and validation for the determination of favipiravir in spiked 7human plasma by using RP-HPLC. J Pharm Res Int. 2021 Oct 26;33(47):275-81.
  46. Khursheed R, Wadhwa S, Kumar B, Gulati M, Gupta S, Chaitanya MV, Kumar D, Jha NK, Gupta G, Prasher P, Chellappan DK. Development and validation of RP-HPLC based bioanalytical method for simultaneous estimation of curcumin and quercetin in rat's plasma. South African Journal of Botany. 2022 Sep 1; 149:870-7.
  47. Pandya RH, Rathod R, Maheswari DG. Bioanalytical method development and validation for simultaneous determination of linagliptin and metformin drugs in human plasma by RP-HPLC method. Pharmacophore. 2014;5(2-2014):202-18.
  48. Jain HK, Deore DD. Bioanalytical method development and validation for estimation of clopidogrel bisulfate in human plasma by RP-HPLC. Int J Appl Pharm. 2016; 8:18-21.
  49. Dalvi AV, Uppuluri CT, Bommireddy EP, Ravi PR. Design of experiments-based RP–HPLC bioanalytical method development for estimation of Rufinamide in rat plasma and brain and its application in pharmacokinetic study. Journal of Chromatography B. 2018 Dec 1; 1102:74-82.
  50. Veni GK, Ajitha A, Abbulu K. Bioanalytical method development and validation of lenvatinib by rp-hplc method. International journal of pharmaceutical sciences and research. 2020; 27:3313-9.
  51. Kishore D, Prasad KR, Darapureddy C, Phani RS. Development and validation of a new HPLC bioanalytical internal standard method for the analysis of remdesivirin human plasma. Rasayan Journal of Chemistry. 2021 Oct 1;14(4):2639-44.
  52. Madhavi S, Rani AP. Bioanalytical method development and validation for the determination of sofosbuvir from human plasma. Int J Pharm Pharm Sci. 2017 Mar;9(3):35-41.
  53. Eswarudu MM, Rao AL, Vijay K. Bioanalytical method development and validation for simultaneous determination of chlorthalidone and cilnidipine drugs in human plasma by RP-HPLC. International journal of research in pharmacy and chemistry. 2019;9(1):33-44.
  54. Gadag S, Narayan R, Nayak Y, Nayak UY. Bioanalytical RP-HPLC method validation for resveratrol and its application to pharmacokinetic and drug distribution studies. Journal of Applied Pharmaceutical Science. 2022 Feb 5;12(2):158-64.
  55. Bhaumik U, Ghosh A, Chatterjee B, Sengupta P, Darbar S, Roy B, Nandi U, Pal TK. Development and validation of a high-performance liquid chromatographic method for bioanalytical application with rimonabant. Journal of pharmaceutical and biomedical analysis. 2009 May 1;49(4):1009-13.
  56. Gandla K, Lalitha R, Kumar DV, Shruthi PV. Bioanalytical method development and validation of vardenafil in human plasma using RP-HPLC. International Journal of Indigenous Herbs and Drugs. 2020 Feb 29:7-16.
  57. Shimpi PS, Mahajan HS. Bioanalytical method development and validation of tadalafil in human plasma using RP-HPLC. World Journal of Pharmaceutical 19Research. 2020 Jun 6;9(8):902-16.
  58. Nallakumar P, Kumar RS. Bioanalytical method development and validation of teneligliptin using Rp-Hplc in rabbit plasma. World J Pharm Res. 2017 Jul 1; 6:2652-60.
  59. Ameeduzzafar, El-Bagory, I., Alruwaili, N.K., Imam, S.S., Alomar, F.A., Elkomy, M.H., Ahmad, N. and Elmowafy, M., 2020. Quality by design (QbD) based development and validation of bioanalytical RP-HPLC method for dapagliflozin: Forced degradation and preclinical pharmacokinetic study. Journal of Liquid Chromatography & Related Technologies, 43(1-2), pp.53-65.
  60. Phani RC, Prasad KR, Mallu UR. A bioanalytical method development and validation for simultaneous determination of velpatasvir and sofosbuvir in spiked human plasma. Asian Journal of Chemistry. 2017;29(11):2565-9.
  61. Sunder BS, Mittal AK. Bio-analytical method development and validation for simultaneous determination of ledipasvir and sofosbuvir drugs in human plasma by RP-HPLC method. Int J Curr Pharm Res. 2018;10(3):21-6.
  62. Gokul P, Ravichandran S. Bio analytical method development and validation for simultaneous estimation of lercanidipine and atenolol in human plasma by using RP-HPLC. World Journal of Pharmaceutical Research. 2017 Aug 26;6(13):404-17.
  63. Bonagiri P, Malothu N, Nallapaty S, Guntupalli C. Development and validation of a bioanalytical RP-HPLC method for quantification of ifenprodil in rat plasma. Journal of Applied Pharmaceutical Science. 2025 Apr 5;15(5):189-96.
  64. Kachave RN, Mundhe AG. Development and validation of bioanalytical method for determination of nebivolol and valsartan in human plasma by using RP-HPLC. European Pharmaceutical Journal. 2021;68(2):49-58.
  65. Jain N, Jain DK, Jain R, Patel VK, Patel P, Jain SK. Bioanalytical method development and validation for the determination of levocetirizine in pharmaceutical dosage form and human plasma by RP-HPLC. Journal of Applied Pharmaceutical Science. 2016 Oct 29;6(10):063-7.
  66. Babu R, Rao AL, Rao JV. Bioanalytical method development and validation for simultaneous estimation of paracetamol and cefixime by using RP-HPLC in rabbit plasma. Oriental Journal of Chemistry. 2016;32(1):701.
  67. Krishna PS, Eswarudu MM, Priya NS, Gayathri B, Babu PS. Bioanalytical RP-HPLC Method Development and Validation for the determination of metformin hydrochloride in spiked human plasma. International Journal of Pharmaceutical Sciences Review and Research, Article. 2022(28):165-8.
  68. Ashok P, Narenderan ST, Meyyanathan SN, Babu B, Vadivelan R. Development and validation of a RP-HPLC method for estimation of telmisartan in human plasma. International Journal of Applied Pharmaceutics. 2019;11(1):237-40.
  69. Logoyda L. Bioanalytical method development and validation from the simultaneous determination of verapamil and enalapril in the present of enalaprilat by HPLC MS/MS. Int J Appl Pharm. 2018; 10:19-27.
  70. Waditake PD, Kolhe MH, Mate MK, Bhor RJ, Bhalerao PS, Mhaske MP. Stability Indicating Bioanalytical Method Development and Validation for Estimation of Remogliflozin Etabonate by RP-HPLC in Human Plasma. International Journal of Pharmaceutical Investigation. 2024 Oct 1;14(4).
  71. Ware Agasti L, Pekamwar SS. Development and Validation of Bioanalytical Rp-Hplc Method for Determination Of Carvedilol And Development And Validation Of Rp-Hplc Method For Determination Of Carvedilol In Bulk Drug And Formulation.
  72. Varatharajan R, Muralidharan S, Vijayan V, Jaganmohan C. Bio-Analytical Method Development and Validation Of Edaravone By Rp-Hplc: Application To Human Clinical Studies.
  73. Mahmood S, Sengupta P, Mandal UK, Chatterjee B, Taher M. Development, validation and pharmacokinetic application of a simple and robust RP-HPLC method for quantitation of raloxifene in rat plasma. Latin American Journal of Pharmacy. 2017 Jan 1;36(9):1901-7.
  74. Pratap SN, Ratna JV. Development and Validation of a Sensitive and Rapid Bioanalytical RP-HPLC Method for the Quantification of Nebivolol Hydrochloride in Rat Plasma. Current Trends in Biotechnology and Pharmacy. 2022 Oct 21;16(3s):87-95.
  75. Ojha N, Prabhakar B. Bio Analytical Method Development and Validation of Lopinavir In Rat Plasma Using Rp Hplc Method And Its Application In Pharmacokinetics.
  76. Devi ND, Putta MA, Sree YS, Naveena P, Sravani P. A novel bio-analytical method for development of Pethidine in human plasma by RP-HPLC method. Pharm. Net. 2015; 6:2834-5.
  77. Baby NR, Rao SA, Naidu PS, Surla D, Bollab N. Simple and rapid method development and validation of RP-HPLC method for the determination of zidovudine in human plasma. Journal of Pharmacy Research. 2016 Apr;10(4):160-6.
  78. Agrawal A, Sharma M. Bioanalytical Method Development and Validation for Estimation of Daunorubicin and Cytarabine in Blood Plasma by Using RP-HPLC. Journal of Drug Delivery & Therapeutics. 2019 Jul 1;9(4).
  79. Bandopadhyay S, Beg S, Katare OP, Sharma T, Singh B. Integrated analytical quality by design (AQbD) approach for the development and validation of bioanalytical liquid chromatography method for estimation of valsartan. Journal of Chromatographic Science. 2020 Jul 24;58(7):606-21.

Photo
Kiran Ukey
Corresponding author

Government College of Pharmacy, Karad

Photo
Rugved Sathawane
Co-author

Government College of Pharmacy, Karad

Photo
Jayashri Dandale
Co-author

Government College of Pharmacy, Karad

Photo
Indrajeet Gonjari
Co-author

Government College of Pharmacy, Karad

Photo
Pratiksha Rajguru
Co-author

Government College of Pharmacy, Karad

Photo
Kajal Bansode
Co-author

Government College of Pharmacy, Karad

Kiran Ukey*, Indrajeet Gonjari, Pratiksha Rajguru, Kajal Bansode, Rugved Sathawane, Jayashri Dandale, A Comprehensive Review of RP-HPLC In Bioanalytical Method Validation and Sample Preparation, Int. J. Sci. R. Tech., 2025, 2 (6), 270-286. https://doi.org/10.5281/zenodo.15606059

More related articles
Onychomycosis: A Comprehensive Review of Current D...
Mahefuz Attar, Ravi Kurhade, Wasim Bagwan, Muskan Shaikh, ...
Seismic Analysis of Tall Structures Using Shear Wa...
Gaurav Shreevash, Dr. S. S. Kushwah, ...
Formulation and Evaluation of Pineapple Based Herb...
Sanika Kondhalkar, Vishal Madankar, Anil Panchal, ...
Related Articles
Thalassemia: An Extensive Analysis of Epidemiology, Diagnosis, and Treatment App...
Karande Samiksha , Khot Seema, Kumbhar Saee, Dr. S. C. Burli , ...
Phyto Cosmetic Formulation of Vetiver Root: A Comprehensive Study on Stability a...
Lakshmi Tulasi D. D., Naga Sravani C. H., Kusuma J., Chaitanya Sri Lahari O., Swapnika V., Raghava D...
Onychomycosis: A Comprehensive Review of Current Diagnostics and Therapeutics...
Mahefuz Attar, Ravi Kurhade, Wasim Bagwan, Muskan Shaikh, ...